Ad is loading...
DFALX
Price
$27.14
Change
-$0.14 (-0.51%)
Updated
Nov 15 closing price
VTSNX
Price
$129.61
Change
-$0.62 (-0.48%)
Updated
Nov 15 closing price
Ad is loading...

DFALX vs VTSNX

Header iconDFALX vs VTSNX Comparison
Open Charts DFALX vs VTSNXBanner chart's image
DFA Large Cap International I
Price$27.14
Change-$0.14 (-0.51%)
VolumeN/A
CapitalizationN/A
Vanguard Total Intl Stock Index I
Price$129.61
Change-$0.62 (-0.48%)
VolumeN/A
CapitalizationN/A
DFALX vs VTSNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DFALX vs. VTSNX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFALX is a Buy and VTSNX is a Buy.

FUNDAMENTALS
Fundamentals
VTSNX has more cash in the bank: 442B vs. DFALX (5.86B). VTSNX (3.29) and DFALX (3.16) have matching dividends . DFALX was incepted earlier than VTSNX: DFALX (33 years) vs VTSNX (14 years). DFALX is a more actively managed with annual turnover of: 8.00 vs. VTSNX (4.00). DFALX has a lower initial minimum investment than VTSNX: DFALX (0) vs VTSNX (5000000). DFALX annual gain was more profitable for investors over the last year : 13.40 vs. VTSNX (10.92). DFALX return over 5 years is better than : 28.56 vs. VTSNX (15.91).
DFALXVTSNXDFALX / VTSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence33 years14 years-
Gain YTD5.2444.535116%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets5.86B442B1%
Annual Yield % from dividends3.163.2996%
Returns for 1 year13.4010.92123%
Returns for 3 years4.28-5.86-73%
Returns for 5 years28.5615.91179%
Returns for 10 years42.9529.81144%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLSK14.030.05
+0.36%
CleanSpark
BSRR31.33-0.19
-0.60%
Sierra Bancorp
GEHC81.76-1.16
-1.40%
GE HealthCare Technologies
NXTC1.31-0.03
-2.24%
NextCure
RCKT13.98-0.84
-5.67%
Rocket Pharmaceuticals